Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection
Clinical trial NCT03674125 · COMPLETED
Trial details
- NCT number
- NCT03674125
- Sponsor
- GeneOne Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2020-04-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.